Given the complex role of ILC2s in asthma pathogenesis and the potential for therapeutic targeting of these cells, investigating the relationship between ICOS and IL-10 production in ILC2s could provide valuable insights into immune regulation and lead to novel therapeutic approaches for severe asthma. This evidence concerns the gene ICOS and asthma.